Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma

Belamy B. Cheung*, Owen Tan, Jessica Koach, Bing Liu, Michael S Y Shum, Daniel R. Carter, Selina Sutton, Sela T. Po'uha, Louis Chesler, Michelle Haber, Murray D. Norris, Maria Kavallaris, Tao Liu, Geraldine M. O'Neill, Glenn M. Marshall

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Fingerprint Dive into the research topics of 'Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences